🔻Аналитик Cantor Fitzgerald Алетия Янг снизила целевую цену акций PTC Therapeutics (PTCT) до $75 с $85 и сохраняет рейтинг «лучше рынка"

В то время как PTC продала 43% своих лицензионных отчислений компании Royalty Pharma, Янг по-прежнему считает, что в будущем поток роялти имеет потенциал роста по сравнению с ожиданиями.

#ptct

🔼Повышение рейтингов от инвестдомов

#CAH: Wells Fargo Upgrades to Equal Weight from Underweight - PT $127 (from $101)

#CCS: JPMorgan Upgrades to Neutral from Underweight - PT $97 (from $110)

#CIEN: BofA Securities Upgrades to Buy from Neutral - PT $95 (from $70)

#CNC: UBS Upgrades to Buy from Neutral - PT $80 (from $79)

#CRM: KeyBanc Upgrades to Overweight from Sector Weight - PT $440

#GIS: BofA Securities Upgrades to Buy from Neutral - PT $80 (from $78)

#GLPI: JPMorgan Upgrades to Overweight from Neutral - PT $54 (from $49)

#NCLH: Barclays Upgrades to Overweight from Equalweight - PT $32 (from $28)

#PENN: JPMorgan Upgrades to Overweight from Neutral - PT $27 (from $19)

Для обсуждения переходи в чат t.iss.one/USstocksnews_chat

#PTCT: Morgan Stanley Upgrades to Overweight from Equalweight - PT $67

#PTEN: Goldman Sachs Upgrades to Buy from Neutral - PT $10

#PYPL: Wolfe Research Upgrades to Outperform from Peerperform - PT $107

#RHI: Truist Securities Upgrades to Buy from Hold - PT $90

#SGMO: Truist Securities Upgrades to Buy from Hold - PT $7

#SRE: Morgan Stanley Upgrades to Overweight from Equalweight - PT $98 (from $85)

#TASK: Morgan Stanley Upgrades to Overweight from Equalweight - PT $21 (from $18)

#UPBD: Stephens Upgrades to Overweight from Equal Weight - PT $38

@usstocksnews | YouTube | Чат

#UPST: Needham Upgrades to Buy from Hold - PT $100

#VAC: Barclays Upgrades to Overweight from Equalweight - PT $116 (from $97)

#VNOM: KeyBanc Upgrades to Overweight from Sector Weight - PT $62